Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate alpha- and beta-cell function during combination
treatment with saxagliptin in addition to dapagliflozin and metformin compared to placebo in
addition to dapagliflozin and metformin in subjects with T2DM on stable metformin background
therapy.